Okano et al.
JOCArticle
and the extract was washed successively with water and brine, and
dried over Na2SO4. The filtrate was concentrated and purified by
flash chromatography over silica gel with n-hexane/EtOAc (1:1) to
give a crude propargyl alcohol as an oil. This crude propargyl
alcohol was dissolved in 4 N HCl/dioxane (1 mL) at room
temperature, and the mixture was stirred at the same temperature
for 30 min. TsCl (230 mg, 1.21 mmol) in CHCl3 (2 mL) was added
to the mixture. The mixture was cooled to 0 °C and Et3N (1.5 mL)
was added to the mixture, and the resulting mixture was stirred at
room temperature for 30 min. The mixture was partitioned between
EtOAc and water. The organic layer was separated, washed with
water and brine, and dried over Na2SO4. The filtrate was concen-
trated under reduced pressure to give an oily residue, which was
purified by column chromatography over silica gel with n-hexane/
EtOAc (1:1 to 1:2) to give 10a (120 mg, 69% yield, 3 steps): colorless
oil; IR (neat) (cm-1) 3482 (OH), 3282 (NHSO2), 2237 (CtC), 1324
(NHSO2), 1159 (NHSO2); 1H NMR (400 MHz, CDCl3) δ 2.36 (td,
J=6.0, 1.6 Hz, 2H), 2.42 (s, 6H), 3.05-3.11 (m, 4H), 3.67 (ddd, J=
9.2, 6.8, 4.0 Hz, 1H), 4.38-4.43 (m, 1H), 5.43-5.49 (m, 1H),
7.29-7.31 (m, 4H), 7.75-7.77 (m, 4H); 13C NMR (75 MHz,
CDCl3) δ 20.3, 21.5 (2C), 41.6, 48.7, 61.4, 80.5, 83.4, 127.0 (2C),
127.1 (2C), 129.8 (4C), 136.9, 137.1, 143.57, 143.61; MS (FAB) m/z
(%) 437 (MHþ, 100); HRMS (FAB) calcd for C20H25N2O5S2
(MHþ) 437.1205, found 437.1225.
82% yield): colorless oil; IR (neat) (cm-1) 1736 (CdO), 1598
(CdC), 1364 (NSO2), 1171 (NSO2); 1H NMR (500 MHz,
CDCl3) δ 1.96-2.04 (m, 1H), 2.10-2.17 (m, 1H), 2.42 (s, 3H),
2.44 (s, 3H), 3.76 (ddd, J=11.5, 10.5, 6.5 Hz, 1H), 3.84-3.90 (m,
1H), 4.05 (dd, J=9.5, 9.0 Hz, 1H), 4.20 (dd, J=9.5, 2.5 Hz, 1H),
5.09-5.11 (m, 1H), 5.41-5.43 (m, 1H), 7.09-7.12 (m, 1H),
7.24-7.29 (m, 4H), 7.33 (d, J=8.5 Hz, 2H), 7.37 (d, J=8.5 Hz,
2H), 7.65 (d, J=8.5 Hz, 2H), 7.96 (d, J=8.5 Hz, 2H); 13C NMR
(125 MHz, CDCl3) δ 21.6 (2C), 27.5, 47.5, 51.2, 52.4, 116.1,
120.2 (2C), 124.7, 127.5 (2C), 128.2 (2C), 129.0 (2C), 139.7 (2C),
130.0 (2C), 134.3, 134.7, 137.4, 140.7, 144.5, 145.0, 151.5; MS
(FAB) m/z (%) 538 (MHþ, 100); HRMS (FAB) calcd for
C27H28N3O5S2 (MHþ) 538.1470, found 538.1470.
General Procedure for Domino Cyclization of 2-Alkynylazir-
idines and Aryl Isocyanates (Conditions B): Synthesis of 3-(4-Methyl-
phenylsulfonyl)-7-[1-(4-methylphenylsulfonyl)-2-oxo-3-phenylimi-
dazolidin-4-yl]-1-phenyl-4,5-dihydro-1H-1,3-diazepin-2(3H)-one
(14a) (Table 1, Entry 13). To a stirred mixture of 2-alkynylazir-
idine 11a (26.8 mg, 0.0641 mmol) and PhNCO 12a (34.9 μL,
0.321 mmol) in THF (0.6 mL) was added Pd(PPh3)4 (3.7 mg,
0.00320 mmol) at -40 °C, and the resulting mixture was stirred
at the same temperature for 40 min. Concentration under
reduced pressure gave an oily residue, which was purified by
column chromatography over silica gel with n-hexane/EtOAc
(5:2 to 3:2) to give 14a (39.0 mg, 93% yield) and 13a (2.4 mg, 7%
yield).
General Procedure for Preparation of 2-Alkynylaziridines 11:
N-{4-[1-(4-Methylphenylsulfonyl)aziridin-2-yl]but-3-ynyl}-4-methyl-
phenylsulfonamide (11a). To a stirred mixture of the propargyl
alcohol 10a (323 mg, 0.488 mmol) and PPh3 (233 mg, 0.888
mmol) in THF (5 mL) was added diisopropyl azodicarboxylate
(386 μL, 1.15 mmol; 40% in toluene solution) at room tempera-
ture, and the resulting mixture was stirred at the same tempera-
ture for 1 min. Concentration under reduced pressure gave an
oily residue, which was purified by column chromatography
over silica gel with n-hexane/EtOAc (5:4) to give 11a (249 mg,
82% yield): colorless oil; IR (neat) (cm-1) 3300 (NHSO2), 2253
Compound 14a: colorless oil; IR (neat) (cm-1) 1736 (CdO),
1697 (CdO), 1597 (CdC), 1358 (NSO2), 1170 (NSO2); 1H NMR
(500 MHz, CDCl3) δ 2.33-2.44 (m, 2H), 2.41 (s, 3H), 2.44 (s,
3H), 3.65-3.69 (m, 1H), 3.87-3.93 (m, 2H), 4.00 (dd, J=10.0,
3.5 Hz, 1H), 4.40 (dd, J=10.0, 3.5 Hz, 1H), 5.76 (dd, J=6.5, 6.5
Hz, 1H), 7.06-7.09 (m, 1H), 7.15-7.17 (m, 1H), 7.20-7.26 (m,
5H), 7.30-7.40 (m, 7H), 7.96 (d, J=8.5 Hz, 2H), 8.02 (d, J=8.5
Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 21.6, 21.7, 24.6, 47.2,
51.8, 54.2, 119.8 (2C), 120.1, 124.7, 127.6 (2C), 128.5 (2C), 128.6,
128.9 (2C), 129.0 (2C), 129.4 (2C), 129.5 (2C), 129.8 (2C), 134.9,
135.1, 136.8, 137.4, 138.3, 144.5, 145.0, 151.5, 154.8; MS (FAB)
m/z (%) 657 (MHþ, 45), 154 (100); HRMS (FAB) calcd for
C34H33N4O6S2 (MHþ) 657.1842, found 657.1846.
1
(CtC), 1329 (NHSO2), 1161 (NHSO2); H NMR (500 MHz,
CDCl3) δ: 2.32 (td, J=6.5, 1.5 Hz, 2H), 2.34 (d, J=4.5 Hz, 1H),
2.43 (s, 3H), 2.46 (s, 3H), 2.67-2.68 (m, 1H), 3.05 (td, J=6.5, 6.5
Hz, 2H), 3.17-3.20 (m, 1H), 4.77-4.87 (m, 1H), 7.30 (d, J=8.5
Hz, 2H), 7.36 (d, J=8.5 Hz, 2H), 7.73 (d, J=8.5 Hz, 2H), 7.83
(d, J=8.5 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 20.2, 21.5,
21.7, 28.1, 34.7, 41.4, 77.2, 79.8, 127.0 (2C), 128.0 (2C), 129.8
(2C), 129.9 (2C), 134.4, 136.9, 143.6, 145.1; MS (FAB) m/z (%)
419 (MHþ, 54), 154 (100); HRMS (FAB) calcd for C20H23N2-
O4S2 (MHþ) 419.1099, found 419.1112.
General Procedure for Domino Cyclization of 2-Alkynylazir-
idines and Aryl Isocyanates (Conditions A): Synthesis of 1-(4-Methyl-
phenylsulfonyl)-4-[1-(4-methylphenylsulfonyl)-4,5-dihydro-1H-
pyrrol-2-yl]-3-phenylimidazolidin-2-one (13a) (Table 1, Entry 4). To
a stirred mixture of 2-alkynylaziridine 11a (25.2 mg, 0.0603
mmol) and PhNCO 12a (7.2 μL, 0.0663 mmol) in THF (0.6 mL)
was added Pd(PPh3)4 (3.5 mg, 0.00301 mmol) at room tempera-
ture, and the resulting mixture was stirred at the same tempera-
ture for 1 min. Concentration under reduced pressure gave an
oily residue, which was purified by column chromatography over
silica gel with n-hexane/EtOAc (5:2 to 3:2) to give 13a (26.5 mg,
Acknowledgment. This work was supported in part by
Grants-in-Aid for Encouragement of Young Scientists (A)
(H.O.) and for Scientific Research (B) (T.T.) from the
Ministry of Education, Culture, Sports, Science and Techno-
logy of Japan, and Targeted Proteins Research Program.
A.O. is grateful for Research Fellowships from the Japan
Society for the Promotion of Science (JSPS) for Young
Scientist. Appreciation is expressed to Fundamental Studies
in Health Sciences of the National Institute of Biomedical
Innovation (NIBIO).
Supporting Information Available: Experimental proce-
dures and characterization data for all new compounds. This
material is available free of charge via the Internet at http://
pubs.acs.org.
3400 J. Org. Chem. Vol. 75, No. 10, 2010